These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant. Kim DW; Park JW; Willingham MC; Cheng SY Hum Mol Genet; 2014 May; 23(10):2651-64. PubMed ID: 24381310 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor. Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244 [TBL] [Abstract][Full Text] [Related]
6. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α. Fozzatti L; Kim DW; Park JW; Willingham MC; Hollenberg AN; Cheng SY Proc Natl Acad Sci U S A; 2013 May; 110(19):7850-5. PubMed ID: 23610395 [TBL] [Abstract][Full Text] [Related]
9. NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1. Han CR; Park S; Cheng SY Sci Rep; 2017 Dec; 7(1):18080. PubMed ID: 29273766 [TBL] [Abstract][Full Text] [Related]
10. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Cheng SY Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829 [TBL] [Abstract][Full Text] [Related]
11. A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Kaneshige M; Suzuki H; Kaneshige K; Cheng J; Wimbrow H; Barlow C; Willingham MC; Cheng S Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15095-100. PubMed ID: 11734632 [TBL] [Abstract][Full Text] [Related]
12. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2. Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902 [TBL] [Abstract][Full Text] [Related]
13. Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients. Moran C; Agostini M; Visser WE; Schoenmakers E; Schoenmakers N; Offiah AC; Poole K; Rajanayagam O; Lyons G; Halsall D; Gurnell M; Chrysis D; Efthymiadou A; Buchanan C; Aylwin S; Chatterjee KK Lancet Diabetes Endocrinol; 2014 Aug; 2(8):619-26. PubMed ID: 24969835 [TBL] [Abstract][Full Text] [Related]
14. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation. Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867 [TBL] [Abstract][Full Text] [Related]
15. Suppression of adipogenesis by valproic acid through repression of USF1-activated fatty acid synthesis in adipocytes. Yuyama M; Fujimori K Biochem J; 2014 May; 459(3):489-503. PubMed ID: 24511897 [TBL] [Abstract][Full Text] [Related]
17. Constitutive coactivator of peroxisome proliferator-activated receptor (PPARgamma), a novel coactivator of PPARgamma that promotes adipogenesis. Li D; Kang Q; Wang DM Mol Endocrinol; 2007 Oct; 21(10):2320-33. PubMed ID: 17595322 [TBL] [Abstract][Full Text] [Related]
18. The DLK gene is a transcriptional target of PPARγ. Couture JP; Blouin R Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338 [TBL] [Abstract][Full Text] [Related]